A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 26485003.
- Also identified by DOI 10.1371/journal.pcbi.1004518 and PMC identifier 4616621.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Despite their importance in maintaining the integrity of all cellular pathways, the role of mutations on protein-protein interaction (PPI) interfaces as cancer drivers has not been systematically studied. Here we analyzed the mutation patterns of the PPI interfaces from 10,028 proteins in a pan-cancer cohort of 5,989 tumors from 23 projects of The Cancer Genome Atlas (TCGA) to find interfaces enriched in somatic missense mutations. To that end we use e-Driver, an algorithm to analyze the mutation distribution of specific protein functional regions. We identified 103 PPI interfaces enriched in somatic cancer mutations. 32 of these interfaces are found in proteins coded by known cancer driver genes. The remaining 71 interfaces are found in proteins that have not been previously identified as cancer drivers even that, in most cases, there is an extensive literature suggesting they play an important role in cancer. Finally, we integrate these findings with clinical information to show how tumors apparently driven by the same gene have different behaviors, including patient outcomes, depending on which specific interfaces are mutated.
Medical subject headings
- DNA Mutational Analysis
- Neoplasm Proteins
- Neoplasms
- Polymorphism, Single Nucleotide
- Protein Interaction Mapping
- Signal Transduction